Accent Microcell Ltd
Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Raw PDF |
Profit & Loss
Figures in Rs. Crores
Operating Profit |
OPM % |
Interest |
Depreciation |
Profit before tax |
Tax % |
EPS in Rs |
Dividend Payout % |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
TTM: | % |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | % |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
Last Year: | % |
Balance Sheet
Figures in Rs. Crores
Equity Capital |
Reserves |
Total Liabilities |
CWIP |
Investments |
Total Assets |
Cash Flows
Figures in Rs. Crores
Net Cash Flow |
Ratios
Figures in Rs. Crores
Debtor Days |
Inventory Days |
Days Payable |
Cash Conversion Cycle |
Working Capital Days |
ROCE % |
Documents
Announcements
-
General Updates
16 June 2025 - NSE approves trading of 29.46 lakh rights shares at Rs.135 each, raising Rs.39.77 crore.
-
Copy of Newspaper Publication
11 June 2025 - Accent Microcell proposes Rights Issue of 2.95 million shares at Rs.135 each, raising Rs.39.77 crore.
-
Issue of Securities
9 June 2025 - Accent Microcell announces Rs. 39.77 Cr rights issue at Rs. 135 per share, 7 shares per 50 held.
-
General Updates
3 June 2025 - Rights issue of 29.46 lakh shares at ₹135 each, raising ₹39.77 crore, record date June 4, 2025.
-
Structural Digital Database
30 May 2025 - SEBI SDD compliance certificate for FY ended March 31, 2025; no non-compliance observed.
Annual reports
Concalls
-
May 2025Transcript PPT REC
-
Jan 2025TranscriptNotesPPTREC
-
Mar 2024TranscriptNotesPPTREC
Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.